Parametric Portfolio Associates’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$111K Buy
7,011
+1,421
+25% +$29.4K ﹤0.01% 3551
2021
Q4
$258K Buy
5,590
+1,313
+31% +$75.4K ﹤0.01% 3331
2021
Q3
$286K Buy
4,277
+3,159
+283% +$259K ﹤0.01% 3320
2021
Q2
$119K Buy
1,118
+51
+5% +$6.05K ﹤0.01% 3466
2021
Q1
$163K Buy
+1,067
New +$174K ﹤0.01% 3915

Other funds holding TECX

Parametric Portfolio Associates's TECX Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Tectonic Therapeutic (TECX) stake by 25% in Q1 2022, buying an estimated $29.4K and bringing the position to 7,011 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #3551.

Parametric Portfolio Associates first reported a position in TECX in Q1 2021 and has held it in 5 quarters since. The position peaked at $286K in Q3 2021. 80 funds tracked by Wall St. Rank hold TECX as of Q1 2022.

  • Parametric Portfolio Associates held 7,011 shares of Tectonic Therapeutic worth $111K as of Q1 2022.
  • Parametric Portfolio Associates bought 1,421 Tectonic Therapeutic shares in Q1 2022, an estimated $29.4K.
  • Tectonic Therapeutic made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3551 holding.
  • Parametric Portfolio Associates first reported a position in Tectonic Therapeutic in Q1 2021 and has held it in 5 quarters since.
  • Parametric Portfolio Associates's Tectonic Therapeutic position peaked at $286K in Q3 2021.
  • 80 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.